GLP-1 Pills vs Injections: Cost, Access, and What Works

GLP-1 weight loss and diabetes drugs are now available in pill form, offering a needle-free option for the 1 in 8 American adults who have tried these medications. However, clinical trials show that oral GLP-1 drugs like Foundayo and the Wegovy pill produce less weight loss than injectables like Zepbound and Wegovy. While insurance can bring the cost of both forms down to $25 a month, the high out-of-pocket prices for injections and pills continue to expose deep inequities in healthcare access.

How do oral GLP-1 pills compare to injections for weight loss?

For years, blockbuster GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound were only available as injections. The arrival of oral alternatives from drugmakers Eli Lilly and Novo Nordisk feels like a win for anyone avoiding needles. Still, the data shows we should temper our expectations.

Efficacy is the first hurdle. Early studies indicate the pills are not quite as effective as their injectable counterparts. In a clinical trial of over 3,000 people, those taking the highest dose of orforglipron, the generic name for the new Eli Lilly pill called Foundayo, lost an average of 25 pounds over 72 weeks. That equals about 11 percent of their body weight. Participants taking a placebo lost less than 5 pounds, or about 2 percent of their body weight.

These are real results, but they fall short of the injectable standards. Participants who injected Zepbound once a week for 72 weeks lost an average of 50 pounds. Those injecting Wegovy lost an average of 33 pounds.

Then there is the matter of daily routine. The Wegovy pill comes with strict rules. You must take it on an empty stomach in the morning with only a few sips of water, then wait 30 minutes before eating or drinking anything else, including coffee. Foundayo does not carry these same restrictions around food or water, making it a more accessible option for daily use.

Do GLP-1 pills work better for type 2 diabetes?

Weight loss is not the only metric that matters. For patients managing type 2 diabetes, the oral versions might actually be a better fit. One study of 100 people found that those taking oral semaglutide experienced bigger reductions in their blood sugar compared to those on the injectable version, even when the injection group lost more weight. The difference was small, but it offers a promising data point for diabetes management.

What are the side effects of GLP-1 pills versus injections?

Side effects remain a significant hurdle for both forms of the medication. A study comparing the two last year found that patients receiving oral semaglutide had a significantly higher risk of stopping treatment due to side effects.

In clinical trials for injectable Zepbound and Wegovy, 6 to 8 percent of participants left the trial because of adverse side effects. For the pill form, discontinuation rates ranged from 5 to 10 percent. Across the board, the most commonly reported side effects were gastrointestinal, including nausea, constipation, diarrhea, and vomiting.

How much do GLP-1 pills cost without insurance?

This is where the conversation shifts from clinical efficacy to systemic inequality. With insurance, the cost of both oral medications starts at $25 per month. Without insurance, the lowest doses of the pills are $149 per month, with prices increasing for higher doses.

The injections also start at $25 per month with insurance, but self-pay patients face steep costs. Wegovy offers an introductory deal of $199 per month for the first two months of its low doses, but the highest dose runs $399 per month. Zepbound self-pay prices range from $299 to $449 per month depending on dosage.

When the less effective option is the only one a patient can afford out of pocket, we have to ask what kind of healthcare system we are building. These pricing tiers create a two-tiered system where wealthy patients access the most effective treatments, while working class and uninsured Americans are left with cheaper, less potent alternatives.

Are GLP-1 pills cheaper than injections?

Yes, GLP-1 pills are generally cheaper than injections for patients paying out of pocket. Without insurance, oral GLP-1 medications start at $149 per month, whereas injectable Wegovy and Zepbound can cost between $199 and $449 per month. With insurance coverage, both pills and injections can cost as little as $25 per month.

Do you have to take GLP-1 pills on an empty stomach?

It depends on the specific medication. The oral version of Wegovy requires you to take it on an empty stomach with a few sips of water, then wait 30 minutes before eating or drinking anything else, including coffee. The new Eli Lilly pill called Foundayo does not have these food or water restrictions.